Your browser doesn't support javascript.
loading
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations.
Hyman, David M; Tran, Ben; Paz-Ares, Luis; Machiels, Jean-Pascal; Schellens, Jan H; Bedard, Philippe L; Campone, Mario; Cassier, Philippe A; Sarantopoulos, John; Vaishampayan, Ulka; Chugh, Rashmi; Mahipal, Amit; Lockhart, A Craig; Sessa, Cristiana; Zander, Thomas; Ng, Matthew; Curigliano, Giuseppe; Bendiske, Jennifer; Chen, Xueying; Choudhury, Somesh; Graus-Porta, Diana; Lewis, Nancy; Perez Garcia, Jose Manuel; de Miguel-Luken, María José.
Afiliación
  • Hyman DM; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Tran B; Weill Cornell Medical College, New York, NY.
  • Paz-Ares L; Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Machiels JP; Hospital Universitario Virgen del Rocío, Seville, Spain.
  • Schellens JH; Institut Roi Albert II, Brussels, Belgium.
  • Bedard PL; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Campone M; Institut de Recherche Clinique et Expérimentale, Brussels, Belgium.
  • Cassier PA; Université Catholique de Louvain, Brussels, Belgium.
  • Sarantopoulos J; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Vaishampayan U; University Health Network, Toronto, Ontario, Canada.
  • Chugh R; René Gauducheau Centre de Recherche en Cancérologie, Nantes, France.
  • Mahipal A; Centre Regional Leon-Berard, Lyon, France.
  • Lockhart AC; University of Texas Health Science Center San Antonio, San Antonio, TX.
  • Sessa C; Wayne State University, Detroit, MI.
  • Zander T; University of Michigan, Ann Arbor, MI.
  • Ng M; Moffitt Cancer Center, Tampa, FL.
  • Curigliano G; Washington University School of Medicine, St Louis, MO.
  • Bendiske J; Ospedale San Giovanni, Bellinzona, Switzerland.
  • Chen X; University Hospital Cologne, Cologne, Germany.
  • Choudhury S; National Cancer Centre Singapore, Singapore.
  • Graus-Porta D; University of Milano, Milan, Italy.
  • Lewis N; European Institute of Oncology, IRCCS, Milan, Italy.
  • Perez Garcia JM; Novartis Pharmaceuticals, East Hanover, NJ.
  • de Miguel-Luken MJ; Novartis Pharmaceuticals, East Hanover, NJ.
JCO Precis Oncol ; 3: 1-13, 2019 Dec.
Article en En | MEDLINE | ID: mdl-35100734

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JCO Precis Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JCO Precis Oncol Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos